JPRN-UMIN000037327
Completed
N/A
A pilot study for early evaluation and estimation of prognosis of patients with advanced and/or relapsed breast cancer by endocrine and/or CDK4/6 inhibitor combined therapy using estrogen receptor PET - A pilot study for breast cancer by endocrine and/or CDK4/6 inhibitor combined therapy using estrogen receptor PET
ConditionsBreast cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Saitama Medical University
- Enrollment
- 8
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
We compared the values of the positive therapy response (RP) group (lesions with a decrease in the FDG SUVmax >=30% after treatment) and the negative therapy response (RN) group (lesions with a decrease in the FDG SUVmax <30%). The FES SUVmax was significantly different in both groups before (RPpre and RNpre) and after (RPpost and RNpost) treatment. The FES value was high before treatment and low after treatment. A decrease trend like FES changes was observed for the FDG SUVmax).
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. patients with the serum fasting glucose level is more than 150mg/dL at the day of entry 2\. patients who entered to the other clinical trials 28 days before the day of entry
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast CancerBreast CancerBreast NeoplasmBreast Cancer FemaleBreast Cancer InvasiveBreast Cancer Stage IIBreast Cancer Stage IIITriple Negative Breast CancerHormone Receptor-positive Breast CancerHER2-positive Breast CancerTriple Negative Breast NeoplasmsEstrogen Receptor-positive Breast CancerNCT05020860Baylor Breast Care Center185
Completed
N/A
The clinical study for evaluating the early efficacy and safty of alpha-1-adrenoreceptor antagonists in patient with benign prostatic hyperplasia.Benign prostatic hyperplasia (BPH)JPRN-UMIN000005151Department of Renal and Urologic Surgery, Asahikawa Medical University100
Not Yet Recruiting
N/A
VAI pilot studie in glioblastomeNL-OMON21865niversity Medical Center Groningen (departments of radiology and ngmb)10
Completed
N/A
Pilot study for the treatment response evaluation in glioblastoma with vessel architectural imaging (VAI)NL-OMON46808niversitair Medisch Centrum Groningen10
Completed
N/A
Early evaluation of therapy response (targeted therapy and immunotherapy) in patients with metastasized malignant melanoma by multiparametric PET/MR imaging.C43.9Malignant melanoma of skin, unspecifiedDRKS00013925niversitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie62